Gansu Province organizes the results of the continuation of drugs in the organizational collection, and the average price is reduced by 42.73%.

On July 11, the results of the drug organized by Gansu Province were announced. It is reported that the drug collection work is organized by the Provincial Medical Insurance Bureau and the Provincial Public Resources Trading Center is implemented. All the 44 drugs that have expired in the second and fourth batch of national organizations have been successfully continued. On average, an average of 42.73%was reduced. According to the agreed purchase volume, our province is expected to save more than 70 million yuan each year. The consecutive collection results are expected to be implemented in our province in August, and all public medical institutions in the province will implement the consecutive collection results.

Pharmaceutical companies actively participate in the collection. A total of 181 companies have 299 products participating in the bidding, 77 products of 60 companies are qualified for the selection, and 44 products of 41 companies are qualified for alternatives. In this collection, a total of 32 drugs were selected from Gansu enterprises in the collection of Gansu again, accounting for 72.73%. On the basis of reducing prices, the stability of clinical medication was effectively guaranteed.

This episode further squeezed out some of the drugs and high prices of water, with a maximum of 88.77%in the elected price. Among them, the treatment of breast cancer was used for injection of paclitaxel (leukin binding) from 780 yuan per branch to a minimum of 135 yuan per year. In the first year, the first year The province is expected to save a cost of 20 million yuan; Pattarta ammlin flat tablets (i), commonly used by patients with primary hypertension, decreased from 2.8 yuan per table to minimum per piece of 0.31 yuan. Patients can save 908 yuan per year.

This time, the collection of collection and mining adheres to the principle of "recruitment and recruitment, linked volume and price linked", focusing on stable market expectations, stable price levels, stable clinical drugs, comprehensive quality, price, supply, credit, market recognition, etc. The process is carried out in an online application method. The collection procedures are compliant, open and transparent in accordance with the law, and have achieved the expected results. (New Gansu · Daily Gansu.com reporter Zhao Jiongyun)

Source: New Gansu · Daily Gansu.com

Editor in charge: Yang Yang

Supervisor: Mu so strong

- END -